Stay updated on ICT-107 Immunotherapy in GBM Clinical Trial
Sign up to get notified when there's something new on the ICT-107 Immunotherapy in GBM Clinical Trial page.

Latest updates to the ICT-107 Immunotherapy in GBM Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page revision history now shows Revision: v3.5.4, replacing Revision: v3.5.3. This update indicates a new version of the study record without changing its substantive details.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedThe page shows an updated ClinicalTrials.gov software revision indicator, changing the displayed build from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page revision is updated from v3.4.3 to v3.5.0, reflecting a minor version update.SummaryDifference0.0%

- Check84 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check112 days agoChange DetectedRevision: v3.4.2 was added. The older Revision: v3.4.1 notice and the funding-status alert were removed.SummaryDifference0.4%

Stay in the know with updates to ICT-107 Immunotherapy in GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ICT-107 Immunotherapy in GBM Clinical Trial page.